# Choroid plexus tumors in adults: a retrospective mono-institutional study

**Authors:** Elena Anghileri, Paola Gaviani, Anna Amato, Bianca Pollo, Rosina Paterra, Marcello Marchetti, Fabio M. Doniselli, Francesco Restelli, Marica Eoli, Ludmila de Oliveira Muniz Koch, Veronica Redaelli, Andrea Giorgio Botturi, Francesco DiMeco, Paolo Ferroli, Mariangela Farinotti, Antonio Silvani

PMC · DOI: 10.1007/s10072-024-07894-x · Neurological Sciences · 2024-12-02

## TL;DR

This study examines 24 adult cases of choroid plexus tumors, focusing on their clinical features, treatment outcomes, and survival rates.

## Contribution

The study provides a detailed retrospective analysis of adult choroid plexus tumors, emphasizing their rarity and treatment approaches.

## Key findings

- Most adult CPTs are grade 1 tumors located in the ventricular system.
- Surgical resection is the primary treatment, but 76% of patients experienced post-surgery clinical worsening.
- Adjuvant therapy is limited to higher-grade tumors, with no consensus on optimal treatment.

## Abstract

Choroid plexus tumors (CPT) are rare entities, and even rarer in adulthood.

A retrospective consecutive series of 24 adult CPT patients was reviewed.

We described 24 adult CPTs. Clinical onset included cerebellar signs (n = 11, 45.8%), intracranial hypertension signs (n = 8, 33.4%), cranial nerves impairment (n = 5, 20.8%), incidental findings (n = 4, 16.6%), seizures (n = 1, 4.2%), spinal signs (n = 1, 4.2%). At first diagnosis, CPT was mostly located in the ventricular system, but other locations can occur, including the spine (one case); meningeal involvement was present in one, pre-surgical hydrocephalus in one case only. CPT histological grade ranged from grade 1 (n = 17), grade 2 (n = 6), and grade 3 (n = 1). TERTp mutation was detected in 17.6% (n = 3/17). TP53 mutation in 5.9% (n = 1/17). Gross Total, Subtotal, Partial resection and Biopsy were achieved in 17 (70.8%), 3 (12.5%), 3 (12.5%) and 1 (4.2%) of patients, respectively. 76% of cases (n = 16/21) experienced clinical worsening suddenly after surgery for different reasons, and mostly gradually recovered. For three cases no data was available. Adjuvant therapy was performed only for grades 2 and 3. At recurrence, surgery, radiosurgery, radiotherapy and chemotherapy were considered. The median Overall Survival from surgery was 219.25 months (95% CI, 188.83–249.67).

We confirm that CPT can occur in adults and are mostly grade 1 tumors located in the ventricular system. The surgical approach is the gold standard, although 76% of clinical worsening occurred, often transient. Adjuvant treatment was limited to higher grade CPT; however, no consensus has already been achieved about adjuvant therapy.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157]

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, TERT (telomerase reverse transcriptase) [NCBI Gene 7015] {aka CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1}
- **Diseases:** intracranial hypertension (MESH:D019586), cranial nerves impairment (MESH:D003389), cerebellar (MESH:D002526), CPTs (MESH:C535589), tumors (MESH:D009369), seizures (MESH:D012640), CPT (MESH:D016545), hydrocephalus (MESH:D006849)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11920377/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11920377/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC11920377/full.md

---
Source: https://tomesphere.com/paper/PMC11920377